Clinical Trial Update: Safety and Efficacy Study of a Vaccine Against Enterotoxigenic Escherichia Coli (ETEC) to Prevent Moderate to Severe Diarrhea [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing the safety and efficacy of a vaccine against enterotoxigenic Escherichia coli to prevent moderate to severe diarrhea has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea
• Enterotoxigenic Escherichia Coli Infection

Drugs mentioned

• ETEC vaccine (Enterotoxigenic Escherichia coli vaccine)

Snippet

Sponsor: TD Vaccines A/S | Conditions: Diarrhea | Phase 2 | Status: COMPLETED